Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

401.08 +0.92 (+0.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,064,067
Open 401.50
Bid (Size) 400.68 (4)
Ask (Size) 408.70 (1)
Prev. Close 400.16
Today's Range 397.59 - 405.67
52wk Range 320.01 - 448.40
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
Earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation report. 
Via Investor's Business Daily
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines. 
Via InvestorPlace

Performance

YTD
-2.39%
-2.39%
1 Month
-1.89%
-1.89%
3 Month
-5.56%
-5.56%
6 Month
+6.61%
+6.61%
1 Year
+15.72%
+15.72%

More News

Read More
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
Via InvestorPlace
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest
Via Benzinga
2 Fantastic Growth Stocks to Buy Right Now
Via The Motley Fool
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,000 Today
Via Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Via Benzinga
2 Top Growth Stocks to Buy Right Now and Hold Forever
Via The Motley Fool
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.
Via The Motley Fool
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
Via Benzinga
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Via The Motley Fool
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Via The Motley Fool
Making Sense of Amazon CEO Andy Jassy's Latest Letter
Via The Motley Fool
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
Via The Motley Fool
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
Via The Motley Fool
3 Relatively Safe Growth Stocks You Can Buy and Hold
Via The Motley Fool
3 Biotech Stocks Set to Double by 2028
Via InvestorPlace
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Via The Motley Fool
Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
Via The Motley Fool
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
Via The Motley Fool
Could This Stock Be the Next Biotech Buyout?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.